Neogen Chemicals Promoter Group Transfers 21.90% Stake to Family Trusts
Haridas Thakarshi Kanani, a promoter of Neogen Chemicals, gifted 57,78,500 equity shares (21.90%) to Haridas Kanani Family Trust (20%) and H T Kanani Family Trust (1.90%). The transfer occurred on December 31, 2025, via an off-market transaction. Promoter group shareholding remains unchanged. SEBI exemption was obtained.
The transfer is an inter-se gift within the promoter group, and the aggregate promoter/promoter group holding remains unchanged. Therefore, it has minimal direct impact on the company's operations, financials, or market perception.
The transaction involves an inter-se transfer of shares within the promoter group via gift, with no change in the overall promoter/promoter group shareholding. This is a regulatory disclosure and does not represent a new acquisition or sale that would significantly impact the company's financials or operations.
Neogen Chemicals Limited has disclosed an inter-se transfer of 57,78,500 equity shares, representing 21.90% of the company's paid-up equity share capital, through a gift via an off-market transaction. Haridas Thakarshi Kanani, a promoter, transferred 52,76,500 shares (20%) to Haridas Kanani Family Trust and 5,02,000 shares (1.90%) to H T Kanani Family Trust.
This transfer, executed on December 31, 2025, was made pursuant to an exemption granted by SEBI under Regulation 11(5) of the SAST Regulations, as per exemption order number WTM/KCV/CFD/17/2025-26 dated December 30, 2025. The aggregate holding of the Promoter and Promoter group category remains unchanged before and after these transactions.
Following the acquisition, Haridas Kanani Family Trust will be classified as a promoter shareholder, and H T Kanani Family Trust as a promoter group shareholder of Neogen Chemicals Limited.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.